Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85%
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Total Assets
$351.2m
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
11%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Total Assets
$34.1m
CAGR 3-Years
47%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Total Assets
$301.9m
CAGR 3-Years
31%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Total Assets
$7.7m
CAGR 3-Years
-36%
CAGR 5-Years
1%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Total Assets
â‚Ş32m
CAGR 3-Years
-31%
CAGR 5-Years
29%
CAGR 10-Years
20%
Pluri Inc
NASDAQ:PLUR
Total Assets
$35.4m
CAGR 3-Years
-25%
CAGR 5-Years
5%
CAGR 10-Years
-6%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Total Assets?
Total Assets
351.2m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Total Assets amounts to 351.2m USD.

What is Kamada Ltd's Total Assets growth rate?
Total Assets CAGR 10Y
11%

Over the last year, the Total Assets growth was 4%. The average annual Total Assets growth rates for Kamada Ltd have been 17% over the past three years , 18% over the past five years , and 11% over the past ten years .

Back to Top